| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9020866 | Vascular Pharmacology | 2005 | 6 Pages |
Abstract
The CV protective properties of early, short-term CAP treatment were not solely due to a reduction in MAP. Although MAP was higher in OCAP and 2nd G, CV structure resembled that found in WKY and SCAP. The effects of our early treatment appear to be due to chronic blockade of the renin-angiotensin system and its effects on growth of CV tissues and the development of fibrosis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kathleen H. Berecek, Phyllis Reaves, Mohan Raizada,